The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Unimed Pharmaceuticals, Inc.

Unimed Pharmaceuticals, Inc.
 PROFILE
So long, sweet bong. Unimed Pharmaceutical makes Marinol, an appetite-stimulating and nausea-quelling medicine used for treating HIV/AIDS and cancer patients. It is a synthetic form of tetrahydrocannabinol (THC), the primary intoxicant in marijuana. Marinol is used to treat HIV/AIDS and cancer patients. Other drugs sold by Unimed treat urinary tract infections (Maxaquin) and anemia through use of anabolic steroids (Anadrol-50). The firm also makes AndroGel, one of the first testosterone replacement therapies for men approved by the FDA. The company is a subsidiary of Solvay Pharmaceuticals, the US unit of Belgian chemical firm Solvay.

 COMPETITION
Atlantic Technology Ventures, Inc. (ATLC)
Duramed Pharmaceuticals, Inc. (DRMD)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1998 Sales (mil.): 15.90
1-Yr. Sales Growth: 78.7%
Employees: 70
Revenue per employee: $227,142.86

 KEY PEOPLE
• Robert E. Dudley
    CEO

 CONTACT INFO
4 Parkway North, 2nd Fl.
Deerfield, IL 60015
US
Phone: 847-282-5400
Fax: 847-374-8480
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001